What is the ticker symbol for Kiniksa Pharmaceuticals International?

Kiniksa Pharmaceuticals International trades under the ticker KNSA on NASDAQ.

What sector does Kiniksa Pharmaceuticals International operate in?

Kiniksa Pharmaceuticals International is classified in the Healthcare sector (Medical - Pharmaceuticals industry).

How can PortView help analyze KNSA in a portfolio?

PortView shows KNSA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Kiniksa Pharmaceuticals International (KNSA) Stock Analysis

NASDAQHealthcareMedical - Pharmaceuticals

$79.29+0.01%

1-year price historyRange $35.42 – $80.92

52-week range$79.29

$34.00$82.94

What Kiniksa Pharmaceuticals International does

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.

Key metrics

Market cap

$6.04B

P/E (TTM)

88.10

EPS (TTM)

$0.90

Beta

0.09

Dividend yield

0.00%

Revenue / share

$10.84

50-day avg

$70.62

200-day avg

$52.30

52-week high

$82.94

52-week low

$34.00

CEO

Sanj K. Patel

ETFs linked to KNSA

Broad-market and Healthcare sector ETFs an investor holding Kiniksa Pharmaceuticals International is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how KNSA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KNSA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Kiniksa Pharmaceuticals International?: Kiniksa Pharmaceuticals International trades under the ticker KNSA on NASDAQ.
Which exchange is KNSA listed on?: KNSA is listed on NASDAQ.
What sector does Kiniksa Pharmaceuticals International operate in?: Kiniksa Pharmaceuticals International is classified in the Healthcare sector (Medical - Pharmaceuticals industry).
How can PortView help analyze KNSA in a portfolio?: PortView shows KNSA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.